~49 spots leftby Apr 2026

Post-Injury Platelet Biology: Mechanisms and Outcomes

Recruiting in Palo Alto (17 mi)
Overseen byLucy Kornblith, MD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: University of California, San Francisco
No Placebo Group

Trial Summary

What is the purpose of this trial?

Trauma-induced coagulopathy is a central cause of preventable deaths from hemorrhage after injury. The contribution and impact of altered post injury platelet biology on trauma-induced coagulopathy is not well understood despite the pivotal contribution of platelets to normal coagulation and endothelial integrity. The central hypothesis for this study is that severe injury and shock drive altered platelet activation, platelet aggregation, and platelet-endothelial interactions that are associated with increased rates of transfusion, organ failure, and mortality. This study will investigate these causal pathways, mechanisms, and associated outcomes in a prospective observational trauma cohort through collection of biospecimens and detailed clinical data.

Eligibility Criteria

Inclusion Criteria

Adult patients meeting criteria for full trauma team activation and admitted to Zuckerberg San Francisco General Hospital.

Treatment Details

Interventions

  • Observational Study (N/A)

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
Zuckerberg San Francisco General HospitalSan Francisco, CA
Loading ...

Who Is Running the Clinical Trial?

University of California, San FranciscoLead Sponsor
National Institute of General Medical Sciences (NIGMS)Collaborator
University of Colorado, DenverCollaborator
University of UtahCollaborator
University of California, BerkeleyCollaborator

References